Clinical trial
Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population
NCT01619098 is registered in ClinicalTrials.gov with Alison Galbraith as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population
- Lead sponsor
- Alison Galbraith
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- November 30, 2013
- Enrollment
- 1,510 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease, congestive heart failure, hospital readmission, post-discharge care transitions